Loading clinical trials...
Loading clinical trials...
Efficacy and Safety of Chidamide Combined With BEAM(Carmustine, Etoposide Cytarabine and Melphalan) Pretreatment in Autologous Transplantation for T-cell Lymphoma: a Single-center, Single-arm Clinical Study
Conditions
Interventions
Chidamide combined with BEAM
Locations
1
China
Ruijin Hospital
Shanghai, Shanghai Municipality, China
Start Date
May 28, 2022
Primary Completion Date
June 1, 2024
Completion Date
June 1, 2025
Last Updated
September 29, 2022
NCT07389616
NCT07356245
NCT07353840
NCT04068597
NCT06588868
NCT06470451
Lead Sponsor
Ruijin Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions